CASI PHARMACEUTICALS INC's ticker is CASI and the CUSIP is 14757U109.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2021 | $104,000 | -36.2% | 87,500 | -16.8% | 0.00% | – |
| Q2 2021 | $163,000 | -56.3% | 105,200 | -32.3% | 0.00% | – |
| Q1 2021 | $373,000 | +12.0% | 155,288 | +37.5% | 0.00% | – |
| Q4 2020 | $333,000 | +197.3% | 112,917 | +53.7% | 0.00% | – |
| Q3 2020 | $112,000 | -39.1% | 73,477 | 0.0% | 0.00% | – |
| Q2 2020 | $184,000 | +23.5% | 73,477 | +0.7% | 0.00% | – |
| Q1 2020 | $149,000 | -33.8% | 72,976 | 0.0% | 0.00% | – |
| Q4 2019 | $225,000 | -5.1% | 72,976 | +2.8% | 0.00% | – |
| Q3 2019 | $237,000 | +4.9% | 70,978 | +0.4% | 0.00% | – |
| Q2 2019 | $226,000 | +11.3% | 70,674 | +0.1% | 0.00% | – |
| Q1 2019 | $203,000 | -28.3% | 70,574 | +0.1% | 0.00% | – |
| Q4 2018 | $283,000 | +20.9% | 70,474 | +40.9% | 0.00% | – |
| Q3 2018 | $234,000 | -42.8% | 50,012 | +0.6% | 0.00% | – |
| Q2 2018 | $409,000 | +98.5% | 49,733 | +0.7% | 0.00% | – |
| Q1 2018 | $206,000 | +25.6% | 49,400 | -2.0% | 0.00% | – |
| Q4 2017 | $164,000 | – | 50,400 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| IDG-Accel China Growth Fund III Associates L.P. | 7,973,536 | $19,136,000 | 25.80% |
| Consonance Capital Management LP | 10,540,715 | $25,298,000 | 2.70% |
| Wellington Shields & Co., LLC | 1,832,769 | $4,399,000 | 1.58% |
| Tri Locum Partners LP | 1,500,000 | $3,600,000 | 0.89% |
| Wellington Shields Capital Management, LLC | 2,231,765 | $5,356,000 | 0.51% |
| Ghost Tree Capital, LLC | 650,000 | $1,560,000 | 0.37% |
| 1492 Capital Management LLC | 159,486 | $382,000 | 0.11% |
| Ikarian Capital, LLC | 1,268,154 | $3,044,000 | 0.10% |
| Sio Capital Management, LLC | 203,432 | $488,000 | 0.10% |
| Aristides Capital LLC | 63,250 | $152,000 | 0.06% |